Efficacy of Zoledronic Acid in Osteoporosis

Last updated: September 20, 2021
Sponsor: Shinshu University
Overall Status: Active - Recruiting

Phase

2

Condition

Osteoporosis

Treatment

N/A

Clinical Study ID

NCT03183557
Zol2017
  • Ages > 20
  • All Genders

Study Summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Osteoporotic patients who want to take zoledronic acid

Exclusion

Exclusion Criteria:

  • Patients who are allergic to zoledronic acid or vitamin D
  • Patients who are pregnant or breast-feeding
  • Patients who have not taken zoledronic acid for the last 2 years

Study Design

Total Participants: 100
Study Start date:
October 12, 2017
Estimated Completion Date:
June 08, 2025

Connect with a study center

  • Yukio Nakamura

    Matsumoto, Nagano 3908621
    Japan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.